FDA Approves Ozempic for Reducing Risk of Chronic Kidney Disease Progression
Ozempic Expands Its Reach: FDA Approves use for Chronic Kidney Disease in Type 2 Diabetes Patients PLAINSBORO, N.J. — In a groundbreaking move, the U.S.Food and Drug Administration (FDA) has expanded the approved uses of Ozempic, a GLP-1 drug initially approved in 2017 to treat type 2 diabetes, to now include reducing risks associated with … Read more
